Steven Bloembergen

Dr. Steven Bloembergen founded GreenMark Biomedical in Michigan in 2016, with a vision to deliver health based benefits to society through biobased targeting technologies. GreenMark’s mission is to “Enable oral healthcare professionals to preserve teeth through early diagnosis and treatment”. Steven has 30 years of leadership experience in the development and commercialization of biomaterials. He started a company called EcoSynthetix (ECO) in Lansing, Michigan in 1996, now a global corporation. He and his team built a manufacturing capacity for starch nanoparticles in excess of 200 million lbs/yr at production sites in the US and Europe. The company held its IPO in August 2011 (TSX: ECO) and was Canada’s largest IPO in the Cleantech sector. Steven received the Ernst and Young “2012 Entrepreneur of the Year Award”. He developed a broad global IP portfolio and established a network of university collaborators, including the use of starch nanoparticles for dental and medical applications, which resulted in the foundational technology for GreenMark. Steven is the inventor of over 25 patent families related to biomaterials. He received his Ph.D. in Polymer Science and Engineering from the University of Waterloo, Ontario.